iShares Genomics Immunology and Healthcare ETF (IDNA) Price, Holdings, & News

ETF Overview

The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.

Key Stats

• Today's Range: $19.16 to $19.39
• 50-Day Range: $17.92 to $23.11
• 52-Week Range: $17.26 to $25.80
• Volume: 90,825 shs
• Average Volume: 31,120 shs
• Market Capitalization: $102.40 million
• Assets Under Management: $102.77 million
• Dividend Yield: 1.14%
• Net Expense Ratio: 0.47%
• Aggregate Rating: Moderate Buy

IDNA ETF - Frequently Asked Questions

How have IDNA shares performed this year?

iShares Genomics Immunology and Healthcare ETF's stock was trading at $22.63 at the beginning of the year. Since then, IDNA shares have decreased by 14.6% and is now trading at $19.32.
View the best growth stocks for 2025 here.

How do I buy shares of iShares Genomics Immunology and Healthcare ETF?

Shares of IDNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of iShares Genomics Immunology and Healthcare ETF own?

Based on aggregate information from My MarketBeat watchlists, some other companies that iShares Genomics Immunology and Healthcare ETF investors own include iShares Micro-Cap ETF (IWC), The RMR Group (RMR), Waste Connections (WCN), DiamondRock Hospitality (DRH), AUO (AUOTY), American Water Works (AWK) and Triple Flag Precious Metals (TFPM).

Fund Details

• Issuer: iShares
• Fund Name: iShares Genomics Immunology and Healthcare ETF
• Tax Classification: Regulated Investment Company
• Stock Exchange: NYSEARCA
• Current Symbol: NYSEARCA:IDNA
• Inception Date: 6/11/2019
• Fund Manager: Jennifer Hsui, Greg Savage, Paul Whitehead
• Web: N/A
• Phone: N/A

Fund Focus

• Asset Class: Equity
• Benchmark: NYSE FactSet Global Genomics and Immuno Biopharma Index
• Category: Strategy
• Focus: Theme
• Development Level: Blended Development
• Region: Global
• Number of Holdings: 63

Fund Statistics

• Assets Under Management: $102.77 million
• Average Daily Volume: $0.00
• Discount/Premium: -0.07%

Administrator, Advisor and Custodian

• Administrator: State Street Bank and Trust Company
• Advisor: BlackRock Fund Advisors
• Custodian: State Street Bank and Trust Company
• Distributor: BlackRock Investments, LLC
• Transfer Agent: State Street Bank and Trust Company
• Trustee: N/A
• Lead Market Maker: Jane Street

Options

• Optionable: N/A
• Short Interest: 13,500 shs

Miscellaneous

• Outstanding Shares: 5,300,000
• Beta: 1.11
• Creation Unit: 50,000
• Creation Fee: $850.00